Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 28.45
+0.10 (0.35%)
Sep 8, 2026, 1:41 PM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.06 billion as of September 4, 2026. Its market cap has increased by 7.71% in one year.
Market Cap
1.06B
Enterprise Value
1.24B
Revenue
1.22B
Ranking
n/a
PE Ratio
8.14
Stock Price
28.45
ChartMarket Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.06B, a decrease of -45.43%. That is a compound annual growth rate of -16.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.06B | -7.00% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
| Mar 29, 2023 | 1.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 2.26B |
| TSH Biopharm Corporation | 1.95B |
| InnoPharmax | 1.34B |
| GeneFerm Biotechnology | 1.25B |
| Excelsior Biopharma | 1.14B |
| DV Biomed | 999.53M |
| Anxo Pharmaceutical | 972.28M |
| Original BioMedicals | 935.31M |